Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gerresheimer Glass’s Joint Venture Starts Production Of Medical Glassware

This article was originally published in PharmAsia News

Executive Summary

Shuangfeng Gerresheimer Danyang recently started operations in Danyang, Jiangsu province. A joint venture of a Danyang medical glass and packaging firm and German Gerresheimer Glass, the world's third-largest medical glass manufacturer, Shuangfeng Gerresheimer has set up three production bases in Danyang and Zhenjiang. Its products cover Asia, America and Eastern Europe. The Danyang facility will develop and produce world-class sophisticated medical glass products including pre-filled syringes and glass cartridges for the local market. (Click here for more - Chinese Language)

Shuangfeng Gerresheimer Danyang recently started operations in Danyang, Jiangsu province. A joint venture of a Danyang medical glass and packaging firm and German Gerresheimer Glass, the world's third-largest medical glass manufacturer, Shuangfeng Gerresheimer has set up three production bases in Danyang and Zhenjiang. Its products cover Asia, America and Eastern Europe. The Danyang facility will develop and produce world-class sophisticated medical glass products including pre-filled syringes and glass cartridges for the local market. (Click here for more - Chinese Language)

"World's Glass Giant Sets Up Base In Danyang" - xinhuanet.com.cn (6/9/09)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071899

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel